On July 6, 2026, healthcare advocates highlighted new channels for importing specialized oncology therapies under FDA personal use guidelines. For many patients in the United States, managing the cost of advanced treatments like Keytruda (Pembrolizumab) 100mg Injection has become a central focus of care navigation.

At Onco Medicine, we support American patients and clinics by facilitating direct sourcing of authentic, tracked oncology medications. Sourcing through validated international networks allows patients to reduce their overall medication costs by 30% to 70% while maintaining absolute compliance and clinical safety.

FDA Personal Importation & Sourcing Standards

• Regulatory Alignment: The FDA personal importation policy permits individuals to source up to a 90-day supply of prescription oncology drugs, provided they hold a valid prescription from a licensed US practitioner.
• Verified Product Details: Patients can access complete batch documentation, Certificates of Analysis (COA), and origin tracking for the Keytruda Pembrolizumab 100mg Injection directly on our product page.
• Validated Temperature Controls: Monoclonal antibodies are highly temperature-sensitive. Every shipment is dispatched in a validated WHO-GDP cold-chain container, maintaining a strict 2–8°C window with active loggers.

Affordability should never compromise patient safety or treatment efficacy. By managing customs documentation and providing continuous telemetry tracking, Onco Medicine bridges access gaps for advanced immunotherapies across all 50 states. We stand by the clinical authenticity of every single vial we deliver.